Federal Register / Vol. 62, No. 189 / Tuesday, September 30, 1997 / Notices 51115

HCFA, Office of Information Services,

Information Technology Investment

Management Group, Division of HCFA

Enterprise Standards, Attention: John

Rudolph, Room C2–26–17, 7500

Security Boulevard, Baltimore,

Maryland 21244–1850.

Dated: September 19, 1997.

John P. Burke III,

HCFA Reports Clearance Officer, Division of

HCFA Enterprise Standards, Health Care

Financing Administration.

[FR Doc. 97–25909 Filed 9–29–97; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[HCFA-R–192]

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, has submitted to the

Office of Management and Budget

(OMB) the following proposal for the

collection of information. Interested

persons are invited to send comments

regarding the burden estimate or any

other aspect of this collection of

information, including any of the

following subjects: (1) The necessity and

utility of the proposed information

collection for the proper performance of

the agency’s functions; (2) the accuracy

of the estimated burden; (3) ways to

enhance the quality, utility, and clarity

of the information to be collected; and

(4) the use of automated collection

techniques or other forms of information

technology to minimize the information

collection burden.

Type of Information Collection

Request: New Collection; Title of

Information Collection: Evaluation of

the Oregon Medicaid Reform

Demonstration: Adult Interview,

Pediatric Asthma Interview, InsulinDependent Diabetes Interview, Low

Back Pain Interview, Medical Provider

Questionnaire; Form No.: HCFA-R–192;

Use: The survey instruments listed

above are for use in the Evaluation of

the Oregon Medicaid Reform

Demonstration. The Adult and Child

Interviews are designed to collect

information related to health status,

access to care, satisfaction with care and

past health insurance status for adult

and child members of the Oregon Health

Plan (OHP). The Pediatric Asthma

Interview, Insulin-Dependent Diabetes

Interview and Low Back Pain Interview

collect information on quality of care,

utilization of care, satisfaction with care

and health status of OHP members with

selected ‘‘tracer conditions’’. The

Medical Provider Questionnaire is

designed to collect information on how

both participating and non-participating

physicians view OHP; Frequency: Other

One-Time Submission; Affected Public:

Not-for-profit institutions, individuals

and households, business or other forprofit; Number of Respondents: 5,533;

Total Annual Responses: 5,533; Total

Annual Hours: 2,242.

To obtain copies of the supporting

statement for the proposed paperwork

collections referenced above, or to

obtain the supporting statement and any

related forms, E-mail your request,

including your address and phone

number, to Paperwork@hcfa.gov, or call

the Reports Clearance Office on (410)

786–1326. Written comments and

recommendations for the proposed

information collections must be mailed

within 30 days of this notice directly to

the OMB Desk Officer designated at the

following address: OMB Human

Resources and Housing Branch,

Attention: Allison Eydt, New Executive

Office Building, Room 10235,

Washington, D.C. 20503.

Dated: September 19, 1997.

John P. Burke III,

HCFA Reports Clearance Officer, HCFA,

Office of Information Services, Information

Technology Investment Management Group,

Division of HCFA Enterprise Standards.

[FR Doc. 97–25910 Filed 9–29–97; 8:45 am]

BILLING CODE 4120–03–P

HEALTH RESOURCES AND SERVICES

ADMINISTRATION

Guidelines for the Use of Antiretroviral

Agents in Pediatric HIV Infection

AGENCY: Health Resources and Services

Administration, Department of Health

and Human Services.

ACTION: Request for comments.

SUMMARY: The Health Resources and

Services Administration (HRSA) is

requesting comments from all interested

parties on the following document:

‘‘Guidelines for Use of Antiretroviral

Agents in Pediatric HIV Infection’’. The

document was developed by specialists

in the care of HIV-infected infants,

children and adolescents, family

members of HIV-infected children, and

governmental agency representatives at

a meeting on July 9 and 10, 1997,

convened by the National Pediatric and

Family HIV Resource Center (NPHRC)

and HRSA. While the pathogenesis of

HIV infection and the general virologic

and immunologic principles underlying

the use of antiretroviral therapy are

similar for all HIV infected individuals,

there are therapeutic and management

considerations that are unique to HIV

infected infants, children and

adolescents. These include acquisition

of infection through perinatal exposure

for many infected children; in utero

exposure to zidovudine (ZDV) and other

antiretroviral medications in many

perinatally-infected children;

differences in diagnostic evaluation in

perinatal infection; differences in

immunologic markers (eg. CD4+

lymphocyte count) in young children;

changes in pharmacokinetic parameters

with age due to the continuing

development and maturation of organ

systems involved in drug metabolism

and clearance; differences in the clinical

and virologic manifestations of perinatal

HIV infection secondary to the

occurrence of primary infection in a

still-developing, immunologically naive

individual; and special considerations

related to treatment adherence in

children and adolescents. This

document addresses the pediatricspecific issues related to antiretroviral

treatment and provides general

guidelines to physicians caring for

infected children and adolescents.

DATES: Comments on the proposed

guidelines must be received on or before

October 30, 1997 in order to ensure that

HRSA will be able to consider the

comments in preparing the final

guidelines.

ADDRESSES: Written comments to this

notice should be submitted to: The HIV/

AIDS Treatment Information Service,

P.O. Box 6303, Rockville, MD 20849–

6303. Only written comments will be

accepted. After consideration of the

comments, the final document will be

published in the Centers for Disease

Control and Prevention (CDC)

‘‘Morbidity and Mortality Weekly

Report’’ (MMWR).

FOR FURTHER INFORMATION CONTACT:

Copies of the ‘‘Guidelines for the Use of

Antiretroviral Agents in Pediatric HIV

Infection’’ are available from the

National AIDS Clearinghouse (1–800–

458–5231) and on the Clearinghouse

Web sites (http://www.cdcnac.org) and

from the HIV/AIDS Treatment

Information Service (1–800–448–0440;

Fax: 301–519–6616; TTY: 1–800–243–

7012) and on their Web site (http://

www.hivatis.org).

SUPPLEMENTARY INFORMATION: A

Working Group on Antiretroviral

Therapy and Medical Management of

HIV-Infected Children composed of
51116 Federal Register / Vol. 62, No. 189 / Tuesday, September 30, 1997 / Notices

specialists in the care of HIV-infected

infants, children and adolescents,

family members of HIV-infected

children, and governmental agency

representatives was convened by the

National Pediatric and Family HIV

Resource Center (NPHRC), sponsored by

the Health Resources and Services

Administration (HRSA), on July 9 and

10, 1997, to establish and finalize a new

set of guidelines for the treatment of

HIV-infected infants, children and

adolescents. The Working Group was

co-chaired by Dr. James Oleske,

University of Medicine and Dentistry of

New Jersey (UMDNJ)-New Jersey

Medical School, Newark, NJ and Dr.

Gwendolyn Scott, University of Miami,

Miami, FL. The treatment

recommendations provided in this

document are based on published and

unpublished data on HIV infection and

treatment in adults and children and,

when no definitive data were available,

the consensus of the Working Group

participants in the treatment of pediatric

HIV infection. It is the intent of the

Working Group that the guidelines be

regarded as flexible and not supplant

the clinical judgement of experienced

health care providers. It is recognized

that these guidelines will need to be

modified as new information and

experience become available.

Dated: September 24, 1997.

Claude Earl Fox,

Acting Administrator.

[FR Doc. 97–25773 Filed 9–29–97; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Statement of Organization, Functions,

and Delegations of Authority

Part N, National Institutes of Health,

of the Statement of Organization,

Functions, and Delegations of Authority

for the Department of Health and

Human Services (40 FR 22859, May 27,

1975, as amended most recently at 62

FR 37587, July 14, 1997, and

redesignated from Part HN as Part N at

60 FR 56605, November 9, 1995), is

amended as set forth below to reflect the

reorganization of the National Library of

Medicine as follows: The functional

statements of the Division of Extramural

Programs (DEP) and the DEP’s Office of

the Director are updated to reflect

current responsibilities.

Section N–B, Organization and

Functions, under the heading National

Library of Medicine (NL, formerly HNL),

is amended as follows: Delete the

functional statements in their entirety

for the Division of Extramural Programs

(NL5, formerly HNL5) and its Office of

the Director (NL51, formerly HNL51)

and replace them with the following:

Division of Extramural Programs

(NL5, formerly HNL5) (1) Administers

programs to augment and strengthen the

health sciences libraries of the Nation

and to improve biomedical

communications and information

management through grants to, or

contracts with, non-Federal and private

institutions; (2) analyzes and evaluates

extramural programs in relation to

program objectives and national needs

to achieve balanced and effective

support; and (3) provides grants

management, grants processing, and

administrative management services.

Office of the Director (NL51, formerly

HNL51) (1) Plans, directs, and

administers the operations of the

extramural programs; (2) coordinates

collaborative efforts with other NIH

components and Federal agencies in the

general areas of informatics, information

management, networking, health library

support, and publications; and (3)

provides technical and management

assistance to advisory and review

committees.

Dated: September 19, 1997.

Ruth Kirschstein,

Acting Director, National Institutes of Health.

[FR Doc. 97–25822 Filed 9–29–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Substance Abuse and Mental Health

Services Administration Agency

Information Collection Activities:

Submission for OMB Review;

Comment Request

Periodically, the Substance Abuse and

Mental Health Services Administration

(SAMHSA) will publish a list of

information collection requests under

OMB review, in compliance with the

Paperwork Reduction Act (44 U.S.C.

Chapter 35). To request a copy of these

documents, call the SAMHSA Reports

Clearance Officer on (301)443–0525.

1998 National Household Survey on

Drug Abuse —Revision—The National

Household Survey on Drug Abuse

(NHSDA) is a survey of the civilian,

noninstitutionalized population of the

United States, age 12 and over. The data

are used to determine the prevalence of

use of cigarettes, alcohol, and illicit

substances, and illicit use of

prescription drugs. The results are used

by SAMHSA, ONDCP, Federal

government agencies, and other

organizations and researchers to

establish policy, direct program

activities, and better allocate resources.

For 1998, the core NHSDA

questionnaire will remain unchanged.

Special topic modules related to

substance abuse prevention have been

added. The total annual burden estimate

is 34,662 hours as shown below:

Instrument No. of respondents

Responses/

respondent

Hours/responseTotal hour

burden

Screening Form ................................................................................................................ 82,741 1 0.050 4,137

Questionnaire and Verification Form ................................................................................ 25,089 1 1.200 30,107

Screening Verification ....................................................................................................... 2,482 1 0.067 166

Interview Verification ........................................................................................................ 3,763 1 0.067 252

Total ........................................................................................................................... .................... .................... .................... 34,662

Written comments and

recommendations concerning the

proposed information collection should

be sent within 30 days of this notice to:

Dan Chenok, Human Resources and

Housing Branch, Office of Management

and Budget, New Executive Office

Building, Room 10235, Washington,

D.C. 20503.

Substance Abuse and Mental Health

Services Administration Agency

Information Collection Activities:

Proposed Collection; Comment Request

In compliance with Section

3506(c)(2)(A) of the Paperwork